- Home
- Equipment
- north america
- cell free dna
Show results for
Refine by
Cell Free Dna Equipment Supplied In North America
16 equipment items found
Manufactured by:Streck, Inc. based inLa Vista, NEBRASKA (USA)
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with ...
by:CareDx, Inc based inSouth San Francisco, CALIFORNIA (USA)
AlloSeq cfDNA is a minimally invasive blood test that measures the amount of donor-derived cell-free DNA (dd-cfDNA) for transplant surveillance. It is currently only available outside of the United ...
Manufactured by:AccuGenomics, Inc. based inWilmington, NORTH CAROLINA (USA)
Accukit™ ONCO1LB contains a blend of 13 synthetic DNA internal standards (IS) to clinically actionable oncogenic regions of the genome (Table 1). The mixtures are physically and enzymatically fragmented to an average size of ~165bp and are suitable for use as routine spike-in controls for cell-free DNA assays. ...
Manufactured by:SiO2 Materials Science based inAuburn, ALASKA (USA)
The company creates engineered blood collection tubes for the Genomics & Diagnostics market. Specifically, the SiO2 blood collection tubes capture and preserve cell free DNA, cell free RNA, and cancer tumor cells using a single blood sample. Our isolation and preservation technology are a ...
Manufactured by:Oasis Diagnostics based inVancouver, WASHINGTON (USA)
The Pure•SAL Oral Specimen Collection Kit provides a simple non-invasive and rapid platform for isolating “liquid biopsy” specimens including cell free DNA, cell free RNA, exosomes, or proteins in a single step. The harvested, purified saliva specimen is stabilized if required and available for ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Covered by Medicare, Prospera is a transplant rejection assessment test that uses a simple blood draw to evaluate the risk of rejection of a transplanted kidney. Through the use of advanced cell-free DNA technology, Prospera increases a provider’s ability to identify otherwise undetected rejection that might lead to kidney loss. ...
Manufactured by:Oasis Diagnostics based inVancouver, WASHINGTON (USA)
RNAPro•SAL was developed as an easy to use and cost effective tool for the split sample collection of rich sources of RNA miRNA, mRNA and proteins found in saliva. The proprietary RNAPro•SAL kit provides two equivalent samples of saliva which total 1.0 mL of saliva in 1-3 minutes. These may be analyzed later for either RNA or protein components. A unique built in Sample Volume Adequacy ...
Manufactured by:Twist Bioscience based inSouth San Francisco, CALIFORNIA (USA)
NGS-based liquid biopsy is a rapidly evolving application that requires accurate and precise reference standards. The Twist Pan-cancer Reference Standard is a high-quality, standardized control for use in the research and development of NGS-based liquid biopsy assays. This reference standard is ideal for establishing the analytical limit of detection (LoD) for specific cancer variants and as a ...
Manufactured by:Stilla Technologies based inVillejuif, FRANCE
Get ready-to-use, fully-validated panels for the detection and quantification of nucleic acids. Crystal Digital PCR™ kits allows researchers to detect and quantify nucleic acids with ready-to-use, pre-designed assays for fully-validated target panels. These digital PCR panel kits are specially developed by Stilla Technologies and its partners ID Solutions. For fully-customizable kits and/or ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
InVisionFirst®-Lung, a ctDNA NGS liquid biopsy testing 37 genes relevant to the care of patients with advanced NSCLC. Covered for Medicare and other private insurance NSCLC patients who meet specific clinical criteria in the United States. InVisionFirst-Lung® is available world-wide for both commercial and research use. ...
by:BillionToOne Inc. based inMenlo Park, CALIFORNIA (USA)
Shifting the Paradigm of Prenatal Screening: The name of our non-invasive prenatal test (NIPT) is appropriately called “UNITY” as it brings together fetal screening for aneuploidies and recessive conditions. It also represents uniting pregnant patients in more equitable ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
As healthy and diseased tissue interact with the bloodstream, they release both cellular and genetic material into the circulation. These materials are referred to as “cell-free” DNA (cfDNA), and circulating tumor cells (CTCs). Conventional blood collection tubes contain only anti-coagulants, designed to prevent blood ...
by:BillionToOne Inc. based inMenlo Park, CALIFORNIA (USA)
Our molecular counting platform can help quantify nearly undetectable DNA changes, unlocking improvements to non-invasive prenatal screening and liquid ...
Manufactured by:AffinityDNA based inEl Paso, TEXAS (USA)
Our Non-Invasive Prenatal Paternity Test is a cutting-edge test that makes it possible for you to confirm if the man you suspect to be the father of your baby is the biological father. Available from the 9th week of pregnancy, starting from the first day of your last menstrual period, you can get the answer you need with a risk-free DNA test. The Certainty™ test, with court-admissible ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer ...
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
The SureDirect Blood PCR Kit enables direct DNA amplification from many sample types including: liquid blood, dried blood on paper, serum, and plasma. Inhibitor resistance and throughput, common PCR challenges associated with blood samples, are averted through the activity of a newly engineered Taq. Your workflow is streamlined by eliminating the cumbersome DNA extraction step. SureDirect Blood ...